The first Astrazeneca plc trade was made in Q4 2020. Since then BlackRock bought shares ten more times and sold shares on seven occasions. The investor sold all their shares in Q1 2026 and doesn't own any shares in Astrazeneca plc anymore.
ABC Arbitrage SA grew its holdings in AstraZeneca PLC (NASDAQ: AZN) by 210.4% in the third quarter, according to its most recent Form 13F filing with the Sec...
AstraZeneca PLC delivered robust 2025 results, with 9% product sales growth and a 23.4% operating margin, and raised its dividend. AZN targets $80bn in reven...
AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript
AZN misses Q4 EPS and sales estimates, but rallies after projecting mid-to-high single-digit revenue growth and low double-digit EPS growth for 2026.